U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(2)
(3)
(17)
(10)
(16)
(13)
(27)
(32)
(22)
(46)
(33)
(34)
(34)
(22)
(25)
(18)
(19)
(27)
(20)
(29)
(13)
(16)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(161)
(260)
(1)
(1)
(1)
(355)
0 of 6
(1)
(1)
(3)
(2)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(423)
(1)
(1)
0 of 27
(7)
(2)
(38)
(3)
(2)
(2)
(7)
0 of 7
(53)
(6)
(5)
(1)
(3)
(12)
(563)
(1)
(1)
(22)
(41)
(63)
0 of 12
(452)
(1)
(31)
(268)
(1)
0 of 5
(130)
(18)
0 of 2
(103)
(6)
0 of 2
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(2)
(35)
(2)
(7)
(1)
(5)
(2)
(1)
(1)
(3)
(3)
(3)
(4)
(1)
(2)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(32)
(6)
(1)
(6)
(3)
(11)
(2)
(3)
(2)
(4)
(2)
(2)
(2)
(1)
(8)
(1)
(2)
(1)
(4)
(2)
(3)
(3)
(1)
(9)
(8)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(2)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(6)
(1)
(3)
(1)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(11)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(91)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(6)
(2)
(3)
(1)
(9)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(13)
(3)
(3)
(10)
(4)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(1)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(1)
(1)
(11)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(7)
(4)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(5)
(3)
(3)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(10)
(1)
(1)
(10)
(2)
(2)
(2)
(3)
(1)
(2)
(1)
(1)
(14)
(2)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(6)
(1)
(24)
(1)
(20)
(18)
(1)
(1)
(3)
(1)
(5)
(2)
(2)
(7)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(7)
(2)
(2)
(5)
(3)
(8)
(2)
(3)
(2)
(4)
(3)
(6)
(2)
(2)
(2)
(2)
(22)
(2)
(14)
(2)
(3)
(5)
(2)
(2)
(5)
(3)
(3)
(5)
(4)
(2)
(2)
(4)
(4)
(3)
(4)
(64)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(3)
(4)
(2)
(3)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(3)
(14)
(8)
(2)
(7)
(3)
(7)
(2)
(4)
(2)
(15)
(3)
(3)
(5)
(12)
(4)
(2)
(2)
(2)
(4)
(3)
(5)
(3)
(2)
(3)
(3)
(2)
(4)
(2)
(6)
(6)
(3)
(2)
(8)
(5)
(4)
(2)
(2)
(2)
(2)
(7)
(7)
(6)
(2)
(3)
(3)
(31)
(2)
(6)
(3)
(4)
(2)
(6)
(2)
(2)
(13)
(13)
(10)
(2)
(5)
(7)
(5)
(3)
(2)
(2)
(2)
(2)
(5)
(224)
(2)
(2)
(2)
(9)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(10)
(2)
(3)
(4)
(2)
(3)
(5)
(3)
(3)
(83)
(30)
(29)
(7)
(3)
(9)
(2)
(3)
(3)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(5)
(5)
(2)
(3)
(8)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(4)
(2)
(2)
(2)
(13)
(3)
(4)
(42)
(4)
(2)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(2)
(43)
(2)
(2)
(4)
(8)
(8)
(5)
(2)
(3)
(6)
(2)
(2)
(13)
(14)
(2)
(28)
(2)
(122)
(4)
(2)
(2)
(4)
(4)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(2)
(5)
(4)
(2)
(4)
(10)
(3)
(2)
(4)
(2)
(2)
(2)
(5)
(2)
(3)
(22)
(3)
(6)
(2)
(2)
(3)
(2)
(23)
(6)
(3)
(60)
(3)
(22)
(2)
(4)
(6)
(2)
(2)
(2)
(6)
(2)
(2)
(3)
(2)
(2)
(2)
(6)
(2)
(6)
(2)
(14)
(5)
(5)
(4)
(4)
(3)
(18)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(2)
(5)
(3)
(2)
(7)
(13)
(20)
(38)
(3)
(4)
(2)
(2)
(3)
(3)
(2)
(3)
(5)
(118)
(2)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(3)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(6)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(7)
(7)
(3)
(3)
(2)
(3)
(3)
(2)
(2)
(4)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(6)
(3)
(2)
(2)
(2)
(6)
(2)
(2)
(2)
(2)
(14)
(2)
(2)
(8)
(18)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(2)
(3)
(3)
(2)
(86)
(2)
(24)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(2)
(14)
(3)
(6)
(4)
(4)
(8)
(6)
(3)
(2)
(2)
(2)
(10)
(3)
(2)
(3)
(9)
(2)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(4)
(3)
0 of 1000
(4)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(13)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(2)
(1)
(4)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(3)
(4)
(3)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(2)
(5)
(2)
(3)
(3)
(3)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(4)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(4)
0 of 1000
(1)
(6)
(1)
(1)
(2)
(3)
(19)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(4)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(23)
(1)
(2)
(1)
(1)
(3)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(275)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(6)
(2)
(5)
(2)
(3)
(1)
(22)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(1)
(11)
(4)
(1)
(4)
(4)
(4)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(8)
(6)
(4)
(9)
(19)
(3)
(1)
(1)
(1)
(4)
(6)
(1)
(5)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(7)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(9)
(3)
(7)
(1)
(1)
(111)
(4)
(2)
(19)
(1)
(5)
(9)
(1)
(2)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(10)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(125)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(4)
(1)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
0 of 454
(1)
(3)
(10)
(1)
(5)
(2)
(1)
(1)
(155)
(3)
(1)
(1)
(1)
(28)
(3)
(1)
(1)
(149)
(1)
(45)
(1)
(124)
(5)
(1)
(5)
(1)
(4)
0 of 27
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 19
Showing 1 - 20 of 779 results
  • Clinical Recommendations for the Use of Injectable Lenacapavir as HIV Preexposure United States 2025
    Clinical Recommendations for the Use of Injectable Lenacapavir as HIV Preexposure — United States, 2025
    Patel, Rupa R. ;
    Hoover, Karen W.
    09/18/2025 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Abstract: In 2023, approximately 39,000 persons received a diagnosis of HIV in the United States. Although HIV preexposure prophylaxis (PrEP) is highly effective in preventing HIV infection, acceptance of, adherence to, and persistence taking the available oral and injectable PrEP regimens have been suboptimal. CDC PrEP guidelines published in 2021 ...
    Supporting Files Public Domain
  • 2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis in Healthcare Settings
    2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings
    Kofman, Aaron D. ;
    Struble, Kimberly A.
    09/15/2025 | National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
    Abstract: These guidelines update the 2013 “Updated US Public Health Service (PHS) Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis,” hereafter referred to as the 2013 PHS Guidelines.1,2 The availability of new medication options, new information on the window o ...
    Supporting Files Public Domain
  • CDC Publishing Agreement and Manuscript Cover Sheet Updated 20250728
    CDC Publishing Agreement and Manuscript Cover Sheet [Updated 2025-07-28]
    United States. Department of Health and Human Services (HHS). Office of the General Counsel (OGC)  ...
    07/28/2025 | Supplements: Morbidity and Mortality Weekly Report (MMWR)
    This Manuscript Cover Sheet form should be included with manuscript submissions in support of the CDC Public Access Policy.Please Note: This cover sheet undergoes periodic review and update. The most recent update occurred in July, 2025.
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports May 8 2025 Vol 74 No RR1
    Morbidity and Mortality Weekly Report: Recommendations and Reports, May 8, 2025 / Vol. 74 / No. RR-1
    Tanner, Mary R. ;
    O’Shea, Jesse G.
    05/08/2025 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    Nonoccupational postexposure prophylaxis (nPEP) for HIV is recommended when a nonoccupational (e.g., sexual, needle, or other) exposure to nonintact skin or mucous membranes that presents a substantial risk for HIV transmission has occurred, and the source has HIV without sustained viral suppression or their viral suppression information is not kno ...
    Supporting Files Public Domain
  • NIOSH Science Policy Update Individual FitTesting Recommendation for Hearing Protection Devices 202501
    NIOSH Science Policy Update: Individual Fit-Testing Recommendation for Hearing Protection Devices [2025-01]
    National Institute for Occupational Safety and Health. Division of Biomedical and Behavioral Science  ...
    2025-01-01 | NIOSH Numbered Publications
    The following describes the NIOSH policy for determining the attenuation provided by hearing protection devices for individual workers. This statement serves as an update to the 1998 NIOSH Criteria for a Recommended Standard—Occupational Noise Exposure.Recommendation: NIOSH recommends employers use individual, quantitative fit testing to evaluate t ...
    Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 8 2024 Vol 73 No RR4
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 8, 2024 / Vol. 73 / No. RR-4
    Nguyen, Antoinette T. ;
    Curtis, Kathryn M.
    August 8, 2024 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    The 2024 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) comprises recommendations for the use of specific contraceptive methods by persons who have certain characteristics or medical conditions. These recommendations for health care providers were updated by CDC after review of the scientific evidence and a meeting with national ...
    Current Supporting Files Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 8 2024 Vol 73 No RR3
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 8, 2024 / Vol. 73 / No. RR-3
    Curtis, Kathryn M. ;
    Nguyen, Antoinette T.
    August 8, 2024 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    The 2024 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a selected group of common, yet sometimes complex, issues regarding initiation and use of specific contraceptive methods. These recommendations for health care providers were updated by CDC after review of the scientific evidence and a meeting with national e ...
    Current Supporting Files Public Domain
  • SUPPLEMENTARY TOOL Part 1 and 2 An Evaluation Framework for a Novel Process to Codevelop Written and Computable Guidelines
    SUPPLEMENTARY TOOL Part 1 and 2. An Evaluation Framework for a Novel Process to Codevelop Written and Computable Guidelines
    Centers for Disease Control and Prevention (U.S.)
    08/09/2023 | Am J Med Qual. 2023 Sep-Oct;38(5S Suppl 2):S12-S34.
    cdc:133620
    Supporting Files Public Domain
  • SUPPLEMENTARY TABLES AnIntegratedProcessforCoDevelopingandImplementingWritten andComputable Clinical Practice Guidelines
    SUPPLEMENTARY TABLES. An Integrated Process for Co-Developing and Implementing Written and Computable Clinical Practice Guidelines
    Centers for Disease Control and Prevention (U.S.)
    08/09/2023 | Am J Med Qual. 2023 Sep-Oct;38(5S Suppl 2):S12-S34.
    cdc:133620
    Supporting Files Public Domain
  • SUPPLEMENTARY TOOL An Evaluation Framework for a Novel Process to Codevelop Written and Computable Guidelines
    SUPPLEMENTARY TOOL. An Evaluation Framework for a Novel Process to Codevelop Written and Computable Guidelines
    Centers for Disease Control and Prevention (U.S.)
    08/09/2023 | Am J Med Qual. 2023 Sep-Oct;38(5S Suppl 2):S12-S34.
    Supplementary in-depth evaluation tool for guidelines. For an overall evaluation tool, visit: https://stacks.cdc.gov/view/cdc/132419
    Supporting Files Public Domain
  • SUPPLEMENTARY TABLES Adapting Clinical Guidelines for the Digital Age ACG Integrated Process and Evaluation Project Plan Template
    SUPPLEMENTARY TABLES. Adapting Clinical Guidelines for the Digital Age (ACG) Integrated Process and Evaluation Project Plan Template
    Centers for Disease Control and Prevention (U.S.)
    08/09/2023 | Am J Med Qual. 2023 Sep-Oct;38(5S Suppl 2):S12-S34.
    cdc:133620
    Supporting Files Public Domain
  • CDC Guideline Development Decision Tool
    CDC Guideline Development Decision Tool
    Dyann Matson Koffman ;
    Randy Elder
    December, 2021
    A CDC guideline document contains recommendations for practice that carries the authority of the Agency. To strengthen the process for developing CDC guidelines, the Office of Science (OS), Office of Science Quality (OSQ), Guidelines and Recommendations Team has updated the CDC Guideline Development Decision Tool (GDDT).
    Current Public Domain
  • Preexposure prophylaxis for the prevention of HIV infection in the United States 2021 update clinical providers supplement
    Preexposure prophylaxis for the prevention of HIV infection in the United States – 2021 update clinical providers’ supplement
    United States. Public Health Service.  ...
    December 2021
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Providers’ Supplement was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – ...
    Public Domain
  • Preexposure prophylaxis for the prevention of HIV infection in the United States 2021 update a clinical practice guideline
    Preexposure prophylaxis for the prevention of HIV infection in the United States -- 2021 update : a clinical practice guideline
    United States. Public Health Service.  ...
    December 2021
    The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2021 Update – A Clinical Practice Guideline includes revisions to several sections. These revisions are intended to update existing guidance using the current evidence base, to incorporate recent FDA PrEP medication approvals, and to clarify specific aspects of c ...
    Public Domain
  • Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2020
    Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2020
    United States. Advisory Committee on Immunization Practices.  ...
    1/29/2020
    Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American Academy of Pediatrics (www.aap.org), American Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), and American ...
    Current Public Domain
  • Recommended adult immunization schedule for ages 19 years or older United States 2020
    Recommended adult immunization schedule for ages 19 years or older, United States, 2020
    United States. Advisory Committee on Immunization Practices.  ...
    1/29/2020
    Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for DiseaseControl and Prevention (www.cdc.gov), American College of Physicians (www.acponline.org), American Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), and Ame ...
    Current Public Domain
  • Treatment of drugresistant tuberculosis An official ATSCDCERSIDSA clinical practice guideline
    Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
    Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.
    11/15/2019 | American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 10,
    The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on treatment of multidrug-resistant TB (MDR-TB), as well ...
    Current Public Domain
  • Recommended adult immunization schedule for ages 19 years or older United States 2019
    Recommended adult immunization schedule for ages 19 years or older, United States, 2019
    United States. Advisory Committee on Immunization Practices.  ...
    02/01/2019
    cdc:51362Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American College of Physicians (www.acponline.org), Academy of Family Physicians (www.aafp.org), American College of Obstetricians and Gynecologists (www.acog.org), and Am ...
    Superseded Supporting Files Public Domain
  • Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2019
    Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2019
    United States. Advisory Committee on Immunization Practices.  ...
    01/31/2019
    cdc:51363Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American Academy of Pediatrics (www.aap.org), American Academy of Family Physicians (www.aafp.org), and American College of Obstetricians and Gynecologists (www.acog.org). ...
    Superseded Supporting Files Public Domain
  • Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
    Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
    Nelson NP, Link-Gelles R, Hofmeister MG, et al.
    November 2, 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    ACIP recommendation for hepatitis A vaccination for post-exposure prophylaxis and International Travel
    Current Public Domain
1 - 20 / 779